SearchPublisher and Institutes
Sitemap
Medical science
01/2009 Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637 01/2009 Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes 01/2009 Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: A mechanism associated with sickle cell disease 01/2009 Fibrinogen gamma gene 3-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population 01/2009 Bridging of oral anticoagulation with low-molecular-weight heparin: Experience in 373 patients with renal insufficiency undergoing invasive procedures 01/2009 Prescription of fondaparinux in hospitalised patients 01/2009 Trends in prevalence of deep venous thrombosis among hospitalised patients in an Asian institution 01/2009 Ankle exercise and venous blood velocity 01/2009 Obstetric analgesia and anaesthesia in women with inherited bleeding disorders 01/2009 Venous thromboembolism in nonagenarians. Findings from the RIETE Registry 01/2009 Prolactin does not affect human platelet aggregation or secretion 01/2009 Role of viral receptors TLR3, RIG-I and MDA5 in mesothelial tissue-type plasminogen activator and plasminogen activator inhibitor-1 synthesis 01/2009 Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: Kinetics following percutaneous coronary intervention and association with clinical characteristics 01/2009 Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer 01/2009 Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed? 01/2009 Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study 01/2009 Recent developments in topical thrombins 01/2009 Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort 01/2009 Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: Fibrinogen Mannheim V 01/2009 The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice 01/2009 Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin 01/2009 Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients 01/2009 Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL) 01/2009 Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin 01/2009 Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor 01/2009 Absence of platelet-dependent fibrin formation in a patient with Scott syndrome 01/2009 Binding of plasma factor XIII to thrombin-receptor activated human platelets 01/2009 Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation 01/2009 Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and -granule release 01/2009 The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease 01/2009 The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy 01/2009 Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level 01/2009 Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study 01/2009 Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer 01/2009 Association of anaemia and mortality in patients with acute pulmonary embolism 01/2009 Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95) 01/2009 Accuracy of complete compression ultrasound in ruling out suspected deep venous thrombosis in the ambulatory setting. A prospective cohort study 01/2009 Does a fabella-tibial suture alter the outcome for dogs with cranial cruciate ligament insufficiency undergoing arthrotomy and caudal pole medial meniscectomy? 01/2009 A limited surgical approach for pastern arthrodesis in horses with severe osteoarthritis 01/2009 The cranial instrument port in arthroscopy of the canine shoulder joint 01/2009 A biomechanical comparison of 3.5 locking compression plate fixation to 3.5 limited contact dynamic compression plate fixation in a canine cadaveric distal humeral metaphyseal gap model 01/2009 Pressure distribution between the deep digital flexor tendon and the navicular bone, and the effect of raising the heels in vitro 01/2009 Appendicular fracture repair in dogs using the locking compression plate system: 47 cases 01/2009 Effect of bending direction on the mechanical behaviour of interlocking nail systems 01/2009 A preliminary retrospective survey of injuries occurring in dogs participating in canine agility 01/2009 Does Osgood-Schlatter Disease exist in the dog? 01/2009 Surgical approaches for minimally invasive plate osteosynthesis in dogs 01/2009 Feline shoulder arthroscopy using a caudolateral portal, a cadaveric study 01/2009 Traumatic fragmented medial coronoid process in a Chihuahua 01/2009 Conservative management for complete loss of a metatarsal pad in a dog 01/2009 Tibial plateau levelling osteotomy in an alpaca 01/2009 The present state of aspirin and clopidogrel resistance 01/2009 Factor Xa inhibitors - New anticoagulants for secondary haemostasis 01/2009 Anticoagulants of primary haemostasis 01/2009 Patients with oral anticoagulation - Bridging anticoagulation in the perioperative phase 01/2009 Monitoring of anticoagulants of secondary haemostasis 01/2009 Monitoring anticoagulation of primary haemostasis - Estimation of platelet function in whole blood assays 01/2009 Haemostaseologic effects of fractionated snake venoms 01/2009 Established anticoagulants in secondary haemostasis - Vitamin K antagonists, heparins 01/2009 New anticoagulants for secondary haemostasis - Anti IIa inhibitors 01/2009 Novel aspects in the regulation of the leukocyte adhesion cascade 01/2009 Neutrophils launch monocyte extravasation by release of granule proteins 01/2009 The multi-functionality of CD40L and its receptor CD40 in atherosclerosis 01/2009 How much is too much? Interleukin-6 and its signalling in atherosclerosis 01/2009 Effect of natural killer T cell activation on the initiation of atherosclerosis 01/2009 The vulnerable patient: Refocusing on the plaque? 01/2009 The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury 01/2009 Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis 01/2009 Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence 01/2009 Bleeding with anticoagulation therapy Who is at risk, and how best to identify such patients Back